$OPY

Oppenheimer Holdings (OPY) Stock Drops As Quarterly Loss Clouds Value Case

Simply Wall St reports Oppenheimer Holdings (OPY) shares fell 3.7% to $106.64 after results. It cites Q1 2026 revenue of $426.4m versus $346.4m a year earlier, but net income swung to a $20.6m loss from a $30.7m profit, with basic EPS turning to -$1.93 from $2.93. The article notes trailing 12-month net income rose to $97.2m.

Original reporting
Published Aug 2, 2026, 6:21 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 2, 2026, 6:57 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$OPY
Bearish
medium confidence
Mentioned
$OPY
Relevance
6/10
alphai data visualization · based on simplywall.st
Decision brief

The 30-second read

$OPYBearishMed
01

Why it matters

Investors recalibrated the valuation story after Q1 2026 results showed a sharp swing from profit to loss, with negative EPS and a reported quarterly loss, despite revenue resilience and a later Q2 rebound.

02

Market read

A profit-to-loss earnings print with negative EPS is a direct catalyst for OPY’s near-term trading and valuation debate, even as revenue remains resilient.

03

What to watch

The article emphasizes compensation and stock appreciation costs as drivers, but does not quantify balance-sheet risk, client activity trends, or guidance, which could change the earnings-quality interpretation.

Relevance 6/10Novelty 4/10Timing: first trading day after results (pre-market/open reaction)

Background

Simply Wall St frames OPY as a value-labeled capital-markets and wealth platform entering earnings season with a trailing P/E of 11.8x.

Company-level read

Ticker impact

$OPYBearishMedium confidence
Context

Oppenheimer Holdings shares fell 3.7% after results as Q1 2026 swung to a quarterly loss of $20.6m and EPS of -$1.93.

Expected impact

Near-term downside bias until investors see stabilization in profitability and earnings quality metrics.

Evidence & confidence

The article cites a profit-to-loss reversal, EPS turning negative, and highlights compensation/incentive sensitivity, which typically drives multiple compression and volatility around capital-markets earnings.

Market effects

Reinforces that capital-markets/wealth platforms can show earnings volatility even with revenue growth, which can affect sector risk premia.

Primarily US-listed financials sentiment, with read-across to other investment banks and wealth managers’ earnings quality expectations.

Limited direct global spillover; mostly affects US capital-markets valuation narratives.

Counterpoint

The text notes Q2 rebound to net income of $27.4m and revenue growth, suggesting the Q1 loss may be temporary rather than structural.

Key entities

  • Oppenheimer Holdings

    US capital markets and wealth platform; reported Q1 2026 quarterly loss and negative EPS, driving a same-day stock drop.

Related articles

$OPYMedAI 8/10

OPPENHEIMER HOLDINGS INC (OPY): Results of Operations and Financial Condition

OPPENHEIMER HOLDINGS INC (OPY) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex991-20268xkq2pressrelease.htm EX-99.1 Document Exhibit 99.1 Oppenheimer Holdings Inc. Reports Second Quarter 2026 Earnings New York, July 31, 2026 – Oppenheimer Holdings Inc. (NYSE: OPY) (the "Company" or "Firm") today reported net income of $27.4 million or $2.55 bas

$LLYMedAI 8/10

Eli Lilly and Company Q2 Earnings Call Highlights

Eli Lilly (LLY) reported Q2 U.S. revenue up 33% led by ZEPBOUND and MOUNJARO volume, while U.S. price fell 3% (9% excluding rebate and discount estimate changes). International revenue rose in constant currency, with MOUNJARO a key driver. Lilly raised its 2026 revenue outlook to $85B-$87B and guided non-GAAP EPS $35.50-$36.50. It also discussed Medicare GLP-1 coverage expansion and retatrutide Phase III results.